Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Reishia clavigera

ABSTRACT: De novo transcriptome analysis for mechanistic study of endocrine description in Reishia clavigera

PROVIDER: PRJNA279843 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR2040660_1.fastq.gz	Fastqsanger.gz
	SRR2040660_2.fastq.gz	Fastqsanger.gz
	SRR2040661_1.fastq.gz	Fastqsanger.gz
	SRR2040661_2.fastq.gz	Fastqsanger.gz
	SRR2040652_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 20

Similar Datasets

Reishia clavigera

Project description:Reishia clavigera overview

| PRJNA317028 | ENA

Reishia clavigera

Project description:Transcriptomic analysis of Reishia clavigera to organotins reveals the tissue-specific molecular responses associated with imposex development

| PRJNA328900 | ENA

Reishia bronni

Project description:Reishia bronni overview

| PRJNA942417 | ENA

Reishia bronni

Project description:Reishia bronni transcriptome project

| PRJDB11324 | ENA

Concomitant downregulation of neuropeptide precursors in a marine snail with consecutive sexual maturation after a nuclear disaster in Japan

Project description:Consecutive sexual maturation (CSM), an abnormal reproductive phenomenon of a marine snail, Reishia clavigera, has occurred since 2017 in the vicinity of the Fukushima Daiichi Nuclear Power Plant after the nuclear disaster there. To determine the molecular basis for CSM, we conducted transcriptome profiling in the ganglia of normal and CSM snails.

2023-03-29 | GSE212768 | GEO

Grosmannia clavigera UAMH 11153

Project description:Grosmannia clavigera Genome Resequencing

| PRJNA182051 | ENA

Project description:Transcriptomic analysis reveals the endocrine toxicity of tributyltin and triphenyltin on the whelk Reishia clavigera and mechanisms of imposex formation

| PRJNA1073763 | ENA

MLL3 is a de novo Cause of Endocrine Therapy Resistance

Project description:MLL3 is a de novo Cause of Endocrine Therapy Resistance

| PRJNA685435 | ENA

Chromatin state changes in HOXA9/MEIS1 leukemia cells [4C-Seq]

Project description:Aberrant expression of homeobox transcription factor HOXA9 is a central component of the leukemogenic program driven by diverse oncogenes. Here we show that HOXA9 overexpression in myeloid progenitor cells and pro-B cells leads to significant rearrangement of the epigenetic landscape with prominent emergence of cancer specific de novo enhancers. HOXA9 acts as a pioneer factor at the de novo enhancers and is required for recruitment of transcription factor CEBP/a and the histone H3K4 methyltransferase MLL3/MLL4 complex. HOXA9 function at the de novo enhancer is distinct from its physiological role at distal enhancers during normal hematopoietic development. Genetic deletion of MLL3/4 specifically affects the active enhancer signatures at de novo enhancers and inhibits HOXA9/MEIS1-mediated leukemogenesis. Our study reveals a previously uncharacterized role of HOXA9 and the MLL3/4 complex in leukemogenesis and provide mechanistic insights in epigenetic deregulation during malignant transformation.

2018-09-05 | GSE103448 | GEO

RNA expression changes in HOXA9/MEIS1 leukemia cells

2018-09-05 | GSE103447 | GEO